An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis

Clinical and Applied Thrombosis/Hemostasis

Volumn 23, Issue 6, 2017, Pages 579-584

  Aota, Takumi ^a   Wada, Hideo ^a   Yamashita, Yoshiki ^a   Matsumoto, Takeshi ^a   Ohishi, Kohshi ^a   Suzuki, Kei ^a   Imai, Hiroshi ^a   Usui, Masanobu ^a   Isaji, Shuji ^a   Asakura, Hidesaku ^b   Okamoto, Kohji ^c   Katayama, Naoyuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c Yahata Municipal Hospital   (Japan)

Author keywords

diagnostic criteria; DIC; infection; pre DIC

Indexed keywords

ANTITHROMBIN; FIBRIN; FIBRIN DEGRADATION PRODUCT; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; PEPTIDE HYDROLASE;

AGED; AGGLUTINATION TEST; AREA UNDER THE CURVE; ARTICLE; BILIARY TRACT INFECTION; BLOOD CLOTTING TEST; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMOSTASIS; HUMAN; JAPAN; LIVER ABSCESS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY RATE; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPSIS; THROMBOCYTE COUNT; THROMBOSIS; URINARY TRACT INFECTION; BLOOD; EVALUATION STUDY; MIDDLE AGED; PLATELET COUNT; PRACTICE GUIDELINE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTITHROMBIN III; ANTITHROMBINS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN; HUMANS; JAPAN; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLATELET COUNT; PRACTICE GUIDELINES AS TOPIC; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 85027555515     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029616654263     Document Type: Article

References (22)

1. Wada H,. Disseminated intravascular coagulation. Clin Chim Acta. 2004; 344 (1-2): 13-21.
2. Levi M, Schultz M, van der Poll T,. Sepsis and thrombosis. Semin Thromb Hemost. 2013; 39 (5): 559-566.
3. Wada H, Matsumoto T, Yamashita Y, Hatada T,. Disseminated intravascular coagulation: testing and diagnosis. Clin Chim Acta. 2014; 436: 130-134.
4. Iba T, Thachil J,. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan. Int J Hematol. 2016; 103 (3): 253-261.
5. Yamakawa K, Aihara M, Ogura H, Yuhara H, Hamasaki T, Shimazu T,. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis. J Thromb Haemost. 2015; 13 (4): 508-519.
6. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H,. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2015; 13 (1): 31-40.
7. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H,. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost. 2014; 12 (9): 1470-1479.
8. Kobayashi N, Maegawa T, Takada M, Tanaka H, Gonmori H,. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;(49): 265-275.
9. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation-On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost. 2001; 86 (5): 1327-1330.
10. Gando S, Iba T, Eguchi Y, et al.Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006; 34 (3): 625-631.
11. Wada H, Thachil J, Di Nisio M, et al.The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013; 11 (4): 761-767.
12. Takemitsu T, Wada H, Hatada T, et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost. 2011; 105 (1): 40-44.
13. Wada H, Wakita Y, Nakase T, et al. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost. 1995; 74 (3): 848-852.
14. Wada H, Gabazza EC, Nakasaki T, et al. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. Semin Thromb Hemost. 2000; 26 (1): 17-21.
15. Toh CH, Downey C,. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2005; 16 (1): 69-74.
16. Toh CH, Hoots WK,. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007; 5 (3): 604-606.
17. Egi M, Morimatsu H, Wiedermann CJ, et al. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels. Thromb Haemost. 2009; 101 (4): 696-705.
18. Wada H, Hatada T, Okamoto K, et al.Japanese Society of Thrombosis Hemostasis/DIC subcommittee. Modified non-overt DIC diagnostic criteria predict the early phase of overt-DIC. Am J Hematol. 2010; 85 (9): 691-694.
19. The committee for DIC diagnostic criteria in Japanese Society of Thrombosis and hemostasis. Diagnostic criteria for disseminated intravascular coagulation by the Japanese Society on Thrombosis and Hemostasis; tentative criteria. Jap J Thromb Hemost. 2014; 25 (5): 629-646.
20. Wada H, Matsumoto T, Hatada T,. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. Expert Rev Hematol. 2012; 5 (6): 643-652.
21. Wada H, Tomeoku M, Kuto M, Deguchi K, Shirakawa S,. FVIII related antigen in malignant diseases: discrepancy between enzyme immunoassay (EIA. and quantitative immunoelectrophoresis. Acta Hematologica Japonica. 1983; 46 (4): 189-200.
22. Wada H, Wakita Y, Nakase T, et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol. 1996; 51 (4): 255-260.